688506 Stock Overview

Engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. More details

688506 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	4/6
Financial Health	6/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (20.6x) is below the CN market (35.7x)

Became profitable this year

Risk Analysis

Earnings are forecast to decline by an average of 102% per year for the next 3 years

My Notes

Capture your thoughts, links and company narrative

Sichuan Biokin Pharmaceutical Co.,Ltd. Competitors

Shanghai Allist Pharmaceuticals

SHSE:688578

CN¥27.5b

China Resources Sanjiu Medical & Pharmaceutical

SZSE:000999

CN¥57.9b

Beijing Tongrentang

SHSE:600085

CN¥56.6b

Shanghai Fosun Pharmaceutical (Group)

SHSE:600196

CN¥61.1b

Price History & Performance

Summary of share price highs, lows and changes for Sichuan Biokin PharmaceuticalLtd
Historical stock prices
Current Share Price	CN¥194.97
52 Week High	CN¥246.31
52 Week Low	CN¥106.03
Beta	0
1 Month Change	-11.05%
3 Month Change	19.54%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	64.31%

Recent updates

Shareholder Returns

	688506	CN Pharmaceuticals	CN Market
7D	-0.8%	-1.9%	-0.6%
1Y	n/a	-5.7%	8.3%

Return vs Industry: Insufficient data to determine how 688506 performed against the CN Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 688506 performed against the CN Market.

Price Volatility

Is 688506's price volatile compared to industry and market?
688506 volatility
688506 Average Weekly Movement	10.3%
Pharmaceuticals Industry Average Movement	7.3%
Market Average Movement	8.7%
10% most volatile stocks in CN Market	12.9%
10% least volatile stocks in CN Market	5.6%

Stable Share Price: 688506 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 688506's weekly volatility (10%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2006	2,264	Yi Zhu	www.baili-pharm.com

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd.

Sichuan Biokin Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Sichuan Biokin PharmaceuticalLtd's earnings and revenue compare to its market cap?
688506 fundamental statistics
Market cap	CN¥78.18b
Earnings (TTM)	CN¥3.80b
Revenue (TTM)	CN¥5.85b

20.6x

P/E Ratio

13.4x

P/S Ratio

Is 688506 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688506 income statement (TTM)
Revenue	CN¥5.85b
Cost of Revenue	CN¥272.85m
Gross Profit	CN¥5.57b
Other Expenses	CN¥1.77b
Earnings	CN¥3.80b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Mar 29, 2025

Earnings per share (EPS)	9.48
Gross Margin	95.33%
Net Profit Margin	64.99%
Debt/Equity Ratio	36.2%

How did 688506 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/27 09:54
End of Day Share Price	2024/12/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sichuan Biokin Pharmaceutical Co.,Ltd. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Shitong Han	Citic Securities Co., Ltd.
Wenxin Yu	Haitong International Research Limited